CDX2 and colorectal carcinoma: In a large retrospective study, the absence of CDX2 expression, which regulates gastrointestinal epithelial development and maturation [3–6], was proposed as a poor prognostic and predictive biomarker for the response to chemotherapy in stages II and III CRC [7].